{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:04:54Z","timestamp":1790424294930,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T00:00:00Z","timestamp":1438905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s11239-015-1259-6","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T01:58:48Z","timestamp":1438826328000},"page":"678-683","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["The role of N-acetylcysteine in the treatment of thrombotic thrombocytopenic purpura"],"prefix":"10.1007","volume":"41","author":[{"given":"Amihai","family":"Rottenstreich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarit","family":"Hochberg-Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Rund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9533-5775","authenticated-orcid":false,"given":"Yosef","family":"Kalish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,7]]},"reference":[{"key":"1259_CR1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/(SICI)1096-8652(199702)54:2<102::AID-AJH2>3.0.CO;2-0","volume":"54","author":"R Sarode","year":"1997","unstructured":"Sarode R, Gottschall JL, Aster RH, McFarland JG (1997) Thrombotic thrombocytopenic purpura: early and late responders. Am J Hematol 54:102\u2013107","journal-title":"Am J Hematol"},{"key":"1259_CR2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","volume":"413","author":"GG Levy","year":"2001","unstructured":"Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD Jr, Ginsburg D, Tsai HM (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413:488\u2013494","journal-title":"Nature"},{"key":"1259_CR3","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","volume":"339","author":"M Furlan","year":"1998","unstructured":"Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339:1578\u20131584","journal-title":"N Engl J Med"},{"issue":"25","key":"1259_CR4","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1182\/blood-2014-11-551580","volume":"125","author":"FA Sayani","year":"2015","unstructured":"Sayani FA, Abrams CS (2015) How I treat refractory thrombotic thrombocytopenic purpura. Blood 125(25):3860\u20133867","journal-title":"Blood"},{"key":"1259_CR5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(77)90612-2","volume":"2","author":"LF Prescott","year":"1977","unstructured":"Prescott LF, Park J, Ballantyne A, Adriaenssens P, Proudfoot AT (1977) Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet 2:432\u2013434","journal-title":"Lancet"},{"key":"1259_CR6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1172\/JCI41062","volume":"121","author":"J Chen","year":"2011","unstructured":"Chen J, Reheman A, Gushiken FC, Nolasco L, Fu X, Moake JL, Ni H, Lopez JA (2011) N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice. J Clin Invest 121:593\u2013603","journal-title":"J Clin Invest"},{"key":"1259_CR7","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/trf.12440","volume":"54","author":"GW Li","year":"2014","unstructured":"Li GW, Rambally S, Kamboj J, Reilly S, Moake JL, Udden MM, Mims MP (2014) Treatment of refractory thrombotic thrombocytopenic purpura with N-acetylcysteine: a case report. Transfusion 54:1221\u20131224","journal-title":"Transfusion"},{"key":"1259_CR8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1056\/NEJMc1213206","volume":"368","author":"J Shortt","year":"2013","unstructured":"Shortt J, Oh DH, Opat SS (2013) ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura. N Engl J Med 368:90\u201392","journal-title":"N Engl J Med"},{"key":"1259_CR9","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2141.2012.09084.x","volume":"157","author":"J Chapin","year":"2012","unstructured":"Chapin J, Weksler B, Magro C, Laurence J (2012) Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura. Br J Haematol 157:772\u2013774","journal-title":"Br J Haematol"},{"key":"1259_CR10","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1182\/asheducation.V2012.1.604.3798564","volume":"2012","author":"JN George","year":"2012","unstructured":"George JN, Al-Nouri ZL (2012) Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes. Hematology Am Soc Hematol Educ Program 2012:604\u2013609","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1259_CR11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","volume":"325","author":"GA Rock","year":"1991","unstructured":"Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 325:393\u2013397","journal-title":"N Engl J Med"},{"key":"1259_CR12","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1182\/blood-2010-07-271445","volume":"116","author":"JN George","year":"2010","unstructured":"George JN (2010) How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood 116:4060\u20134069","journal-title":"Blood"},{"key":"1259_CR13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1365-2362.2001.00815.x","volume":"31","author":"G Anfossi","year":"2001","unstructured":"Anfossi G, Russo I, Massucco P, Mattiello L, Cavalot F, Trovati M (2001) N-acetyl-l-cysteine exerts direct anti-aggregating effect on human platelets. Eur J Clin Invest 31:452\u2013461","journal-title":"Eur J Clin Invest"},{"key":"1259_CR14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11239-012-0723-9","volume":"34","author":"NM Tun","year":"2012","unstructured":"Tun NM, Villani GM (2012) Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: a systematic review with pooled data analysis. J Thromb Thrombolysis 34:347\u2013359","journal-title":"J Thromb Thrombolysis"},{"key":"1259_CR15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s002770050549","volume":"78","author":"F Ferrara","year":"1999","unstructured":"Ferrara F, Copia C, Annunziata M, Spasiano A, Di Grazia C, Palmieri S, Prossomariti L, Mele G (1999) Vincristine as salvage treatment for refractory thrombotic thrombocytopenic purpura. Ann Hematol 78:521\u2013523","journal-title":"Ann Hematol"},{"key":"1259_CR16","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1111\/trf.12787","volume":"54","author":"J Shortt","year":"2014","unstructured":"Shortt J, Opat SS, Wood EM (2014) N-Acetylcysteine for thrombotic thrombocytopenic purpura: is a von Willebrand factor-inhibitory dose feasible in vivo? Transfusion 54:2362\u20132363","journal-title":"Transfusion"},{"key":"1259_CR17","unstructured":"Cumberland Pharmaceuticals, Inc. Acetadote (acetylcysteine) injection. Package insert 2013"},{"key":"1259_CR18","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1097\/CCM.0b013e31819ffed4","volume":"37","author":"DN Wijeysundera","year":"2009","unstructured":"Wijeysundera DN, Karkouti K, Rao V, Granton JT, Chan CT, Raban R, Carroll J, Poonawala H, Beattie WS (2009) N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery. Crit Care Med 37:1929\u20131934","journal-title":"Crit Care Med"},{"key":"1259_CR19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.mbc.0000195922.26950.89","volume":"17","author":"TT Niemi","year":"2006","unstructured":"Niemi TT, Munsterhjelm E, Poyhia R, Hynninen MS, Salmenpera MT (2006) The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm. Blood Coagul Fibrinolysis 17:29\u201334","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1259_CR20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/gut.2004.043505","volume":"54","author":"TT Knudsen","year":"2005","unstructured":"Knudsen TT, Thorsen S, Jensen SA, Dalhoff K, Schmidt LE, Becker U, Bendtsen F (2005) Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects. Gut 54:515\u2013521","journal-title":"Gut"},{"key":"1259_CR21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3109\/00365519409088566","volume":"54","author":"S Jepsen","year":"1994","unstructured":"Jepsen S, Hansen AB (1994) The influence of N-acetylcysteine on the measurement of prothrombin time and activated partial thromboplastin time in healthy subjects. Scand J Clin Lab Invest 54:543\u2013547","journal-title":"Scand J Clin Lab Invest"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-015-1259-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-015-1259-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-015-1259-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T22:32:45Z","timestamp":1599431565000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-015-1259-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["1259"],"URL":"https:\/\/doi.org\/10.1007\/s11239-015-1259-6","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,7]]}}}